Mindray North America, a subsidiary of Shenzhen, China–based Mindray, said today that it has inked a U.S. distribution agreement for its Hepatus-Series transient elastography diagnostic ultrasound systems.
The new strategic agreement makes Dublin, Ohio–based Aegle Medical Solutions the sole distributor of the Hepatus-Series systems.
The Hepatus-Series ultrasound systems use transient elastography, a noninvasive tool for measuring liver stiffness, to enable better liver disease management, according to Mindray. The Hepatus-Series systems include new quantitative tools for evaluating liver disease. Mindray describes the systems as easy to use, providing a reliable way to diagnose liver fibrosis and liver steatosis.
“As liver disease continues to grow as an epidemic, it is important for us to continuously find new ways to better serve patients by enabling their clinicians to get a clear view of liver health with innovative technologies and quantitative tools that are reliable,” Wayne Quinn, Mindray North America’s president, said in a news release.
“The partnership with Aegle to distribute the Hepatus-Series ultrasound systems provides us with an excellent opportunity to better serve those patients and expand our liver care offerings in the U.S. market.”
Aegle Medical CEO Michael McTighe expressed his excitement: “At Aegle Medical, we are dedicated to supporting healthcare professionals with emerging technologies that improve their clinical confidence, diagnostic accuracy, and overall patient satisfaction, and that is exactly what Mindray has developed and delivered to the market with the introduction of the Hepatus platform.”